A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 46,022 shares of RVMD stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,022
Previous 51,991 11.48%
Holding current value
$2.09 Million
Previous $1.68 Million 6.63%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $179,905 - $242,818
-5,969 Reduced 11.48%
46,022 $1.79 Million
Q1 2024

May 15, 2024

SELL
$26.56 - $33.55 $366,528 - $462,989
-13,800 Reduced 20.98%
51,991 $1.68 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $232,879 - $433,016
12,691 Added 23.9%
65,791 $1.89 Million
Q3 2023

Nov 14, 2023

SELL
$25.17 - $35.05 $571,359 - $795,634
-22,700 Reduced 29.95%
53,100 $1.47 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $2.03 Million - $2.7 Million
-99,900 Reduced 56.86%
75,800 $2.03 Million
Q1 2023

May 15, 2023

SELL
$20.76 - $30.09 $80,964 - $117,351
-3,900 Reduced 2.17%
175,700 $3.81 Million
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $189,176 - $273,171
-10,700 Reduced 5.62%
179,600 $4.28 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $1.45 Million - $2.16 Million
83,100 Added 77.52%
190,300 $3.75 Million
Q2 2022

Aug 15, 2022

SELL
$14.54 - $27.17 $331,512 - $619,476
-22,800 Reduced 17.54%
107,200 $2.09 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $770,295 - $1.17 Million
44,500 Added 52.05%
130,000 $3.32 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $33.7 $477,260 - $660,520
19,600 Added 29.74%
85,500 $2.15 Million
Q3 2021

Nov 15, 2021

BUY
$23.95 - $33.41 $1.35 Million - $1.88 Million
56,200 Added 579.38%
65,900 $1.81 Million
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $145,000 - $237,200
5,000 Added 106.38%
9,700 $308,000
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $174,887 - $255,821
4,700 New
4,700 $216,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.97B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.